NEW YORK (GenomeWeb News) — Oregon Health and Science University has licensed several of GeneGo’s data analysis software platforms for use in its Affymetrix Microarray Core facility, GeneGo said today.
 
Under the agreement, the OHSU microarray facility will use GeneGo’s MetaCore for pathways analysis, its MapEditor for pathway editing and communications, and its MetaLink for adding interactions to MetaCore-curated pathways.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.